AID FOR TRADE Stocktaking Event "Mobilizing Resources to Build Resilient Local Pharmaceutical Manufacturing Industries in Developing Countries - Challenges and Opportunities"

Date
-

The COVID-19 pandemic has highlighted the strategic imperative of building resilient manufacturing capacity for essential medicines and vaccines in developing countries and regions. There is the potential to improve availability of essential medicines and accelerate access to novel products whilst protecting the innovation ecosystems that have so rapidly developed COVID19 vaccines. Developing the assets that can achieve these ends requires an ecosystem that ensures sustainable high-quality production.






Quality & Standards

Global Quality and Standards Programme Vietnam

Feb-11-2021

Fact sheet

Attachment Size
DOWNLOAD HERE 419.96 KB